ArticleJMIR formative research2025
The Impact of a Digital Digestive Health Program and Telehealth Visits in Socially Vulnerable Populations: Cohort Evaluation.
Article in JMIR formative research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Diet and ileostomy: a qualitative comparison of patient and healthcare professional perspectives in the United Kingdom and Australia.European journal of nutrition · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSocially vulnerable populations have less access to quality gastrointestinal (GI) care. Digital telehealth services provided by GI-focused registered dietitian nutritionists (RDNs) and digestive health coaches (HCs) may improve digestive health outcomes by facilitating access to GI care and thereby reduce health care disparities among vulnerable populations.
objectiveThe objectives of this study were to (1) evaluate the impact of a digital digestive health program on reducing GI symptoms among socially vulnerable populations and (2) assess whether telehealth visits with digital app use provide additional benefits in symptom reduction compared to digital app use alone among socially vulnerable populations.
methodsA comprehensive digital digestive care program with optional telehealth visits with RDNs and HCs was provided to US employees of participating companies via their employee benefits. We enrolled participants in the program between 2022 and 2023 who tracked digestive symptoms multiple times at baseline and then over 90 days. We measured changes in GI symptoms from baseline to up to 3 months, comparing those who opted for telehealth visits with those who used the app only. We stratified participants by the median Social Vulnerability Index (SVI) to evaluate symptom improvement across socially vulnerable populations. Multivariable regressions adjusted for age, gender, race, BMI, and preexisting GI conditions.
resultsA total of 1656 participants met the inclusion criteria, of which 1362 (82%) scheduled at least one telehealth visit and 294 (18%) used only app-based resources. The majority (n=1417 86%) of participants saw GI symptom improvement, with an average reduction of 60% in symptom burden (P<.001). Participants who used telehealth services and the app had a reduction in symptoms 16% greater than that of app-only users (P=.01). High-SVI participants (ie, those with an SVI score above the median of 0.4, indicating greater social vulnerability) had a 22% greater reduction in GI symptom severity score than app-only high-SVI participants (P=.04).
conclusionsDigital health solutions may be an important resource in advancing equitable access to quality GI care and addressing disparities among populations with high social vulnerability. Virtual telehealth visits with RDNs and HCs appear to be particularly beneficial in improving digestive symptoms in such populations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.